Latest News

digestive tract | Image credit: sdecoret -
Celltrion, Samsung Bioepis Unveil New Biosimilar Data in CD, UC at ECCO 2024

February 23rd 2024

At the Congress of European Crohn’s and Colitis Organisation (ECCO), Celltrion and Samsung Bioepis presented new finding from their respective biosimilar analyses, demonstrating positive safety and efficacy measures for the biosimilars as treatments for Crohn disease (CD) and ulcerative colitis (UC).

eye on pharma banner
Eye on Pharma: VA Picks Hadlima; Biocon, Sandoz Partnership; A Stelara Settlement Abroad

February 21st 2024

syringe and vial | Image credit: Inna Dodor -
Summary of VOLTAIRE-X Study Explains Decision Behind Cyltezo Interchangeability

February 17th 2024

Dermatologist examining skin | Image Credit: fusssergei -
Biosimilar Candidate CT-P43 Shows Biosimilarity With Ustekinumab Originator in Plaque Psoriasis

February 13th 2024

eye on pharma banner
Eye on Pharma: Celltrion Biosimilars Win Tenders; Oral Ustekinumab Device Passes Phase 1 Trial

February 12th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.